IMMIX BIOPHARMA, INC. Public Float
IMMIX BIOPHARMA, INC. (IMMX) had Public Float of $35.71 million as of 2025-06-30, per its 10-K/A filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $35.71M.
- 2024-06-30: Entity Public Float $32.43M.
- 2023-06-30: Entity Public Float $27.96M.
- 2022-06-30: Entity Public Float $18.30M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $35.71M 10-K/A · filed 2026-03-27 |
| 2024-06-30 | $32.43M 10-K/A · filed 2025-05-19 |
| 2023-06-30 | $27.96M 10-K · filed 2024-03-29 |
| 2022-06-30 | $18.30M 10-K · filed 2023-03-27 |
| 2021-06-30 | $24.80M 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |